Works by Rasco, Drew W.

Results: 9
    1
    2
    3

    Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis

    Published in:
    Journal of Clinical Pharmacology, 2018, v. 58, n. 2, p. 180, doi. 10.1002/jcph.988
    By:
    • Gupta, Neeraj;
    • Hanley, Michael J.;
    • Venkatakrishnan, Karthik;
    • Bessudo, Alberto;
    • Rasco, Drew W.;
    • Sharma, Sunil;
    • O'Neil, Bert H.;
    • Wang, Bingxia;
    • Liu, Guohui;
    • Ke, Alice;
    • Patel, Chirag;
    • Rowland Yeo, Karen;
    • Xia, Cindy;
    • Zhang, Xiaoquan;
    • Esseltine, Dixie‐Lee;
    • Nemunaitis, John
    Publication type:
    Article
    4

    Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.

    Published in:
    2018
    By:
    • Goss, Glenwood D.;
    • Vokes, Everett E.;
    • Gordon, Michael S.;
    • Gandhi, Leena;
    • Papadopoulos, Kyriakos P.;
    • Rasco, Drew W.;
    • Fischer, JuDee S.;
    • Chu, Katharine L.;
    • Ames, William W.;
    • Mittapalli, Rajendar K.;
    • Lee, Ho‐Jin;
    • Zeng, Jiewei;
    • Roberts‐Rapp, Lisa A.;
    • Loberg, Lise I.;
    • Ansell, Peter J.;
    • Reilly, Edward B.;
    • Ocampo, Christopher J.;
    • Holen, Kyle D.;
    • Tolcher, Anthony W.;
    • Lee, Ho-Jin
    Publication type:
    journal article
    5

    Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 15, doi. 10.1007/s00280-023-04544-5
    By:
    • Rasco, Drew W.;
    • Medina, Theresa;
    • Corrie, Pippa;
    • Pavlick, Anna C.;
    • Middleton, Mark R.;
    • Lorigan, Paul;
    • Hebert, Chris;
    • Plummer, Ruth;
    • Larkin, James;
    • Agarwala, Sanjiv S.;
    • Daud, Adil I.;
    • Qiu, Jiaheng;
    • Bozon, Viviana;
    • Kneissl, Michelle;
    • Barry, Elly;
    • Olszanski, Anthony J.
    Publication type:
    Article
    6
    7

    Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 4, p. 762, doi. 10.1007/s10637-022-01247-1
    By:
    • LoRusso, Patricia;
    • Ratain, Mark J.;
    • Doi, Toshihiko;
    • Rasco, Drew W.;
    • de Jonge, Maja J. A.;
    • Moreno, Victor;
    • Carneiro, Benedito A.;
    • Devriese, Lot A.;
    • Petrich, Adam;
    • Modi, Dimple;
    • Morgan-Lappe, Susan;
    • Nuthalapati, Silpa;
    • Motwani, Monica;
    • Dunbar, Martin;
    • Glasgow, Jaimee;
    • Medeiros, Bruno C.;
    • Calvo, Emiliano
    Publication type:
    Article
    8
    9